OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE

Product NDC
42571-205
Requested package NDC
42571-205-90
11-digit product format
425710205
Labeler code
42571
Product ID
42571-205_4f799eb1-290a-640c-e063-6294a90ac62b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Olmesartan medoxomil and hydrocholorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Micro Labs Limited
Application
ANDA206371
Marketing category
ANDA
Marketing start
2026-10-15
Substance
OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active strength
40; 12.5 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL12.5MG;20MGTABLET / ORALAB2026-04-13
A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL12.5MG;40MGTABLET / ORALAB2026-04-13
A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL25MG;40MGTABLET / ORALAB2026-04-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A206371-001AB
A206371-002AB
A206371-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MGTABLET / ORALAB2026-04-13d4dbc9d85df4…
2026-11-14 07:37:172026-10A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;40MGTABLET / ORALAB2026-04-13d4dbc9d85df4…
2026-11-14 07:37:172026-10A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE25MG;40MGTABLET / ORALAB2026-04-13d4dbc9d85df4…
2026-10-15 13:18:302026-09A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MGTABLET / ORALAB2026-04-13c2088c7a36db…
2026-10-15 13:18:302026-09A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;40MGTABLET / ORALAB2026-04-13c2088c7a36db…
2026-10-15 13:18:302026-09A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE25MG;40MGTABLET / ORALAB2026-04-13c2088c7a36db…
2026-09-14 22:38:342026-08A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MGTABLET / ORALAB2026-04-1384e616aacf4f…
2026-09-14 22:38:342026-08A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;40MGTABLET / ORALAB2026-04-1384e616aacf4f…
2026-09-14 22:38:342026-08A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE25MG;40MGTABLET / ORALAB2026-04-1384e616aacf4f…
2026-08-18 06:07:402026-07A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MGTABLET / ORALAB2026-04-13caaa826d4ba7…
2026-08-18 06:07:402026-07A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;40MGTABLET / ORALAB2026-04-13caaa826d4ba7…
2026-08-18 06:07:402026-07A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE25MG;40MGTABLET / ORALAB2026-04-13caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-001OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;20MGTABLET / ORALAB2026-04-13a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-002OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE12.5MG;40MGTABLET / ORALAB2026-04-13a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-003OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE25MG;40MGTABLET / ORALAB2026-04-13a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A206371-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A206371-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A206371-003AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A206371-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A206371-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A206371-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08A206371-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A206371-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A206371-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A206371-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206371-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206371-003AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A206371-003AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OLMESARTAN MEDOXOMIL40 mg/1
HYDROCHLOROTHIAZIDE12.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6M97XTV3HDInternal UNII lookup
0J48LPH2THInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
403853Internal RxNorm lookup
403854Internal RxNorm lookup
403855Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
576b315a-4830-42b5-bf5f-76fe4bbc0f8cAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDEOLMESARTAN MEDOXOMIL AND HYDROCHOLOROTHIAZIDEMicro Labs Limited576b315a-4830-42b5-bf5f-76fe4bbc0f8c2026-04-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206371
application number: ANDA206371
ndc (package): 42571-205-90
ndc (product): 42571-205
ndc11 (package): 42571020590

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
42571-205-904257102059090 TABLET, FILM COATED in 1 BOTTLE (42571-205-90) 2026-10-15NoNoCurrent